SUPRIYA — Supriya Lifescience Share News
0.000.00%
Last trade - 00:00- IN₹65.88bn
- IN₹64.87bn
- IN₹8.28bn
Brief: Supriya Lifescience Limited Says June-Quarter Profit 240.4 Million Rupees
India's Supriya Lifescience on track for worst fall in a month on probe into official
Brief: Supriya Lifescience Says Lote Facility Receives USFDA EIR With Voluntary Action Indicated Classification
India's Supriya Lifescience rises on higher quarterly profit
Brief: Supriya Lifescience March-Quarter Profit 742.3 Million Rupees
Brief: Supriya Lifescience Says US FDA Inspects Supriya Lifescience Lote Facility
Brief: Supriya Lifescience Dec-Quarter Profit 496.8 Million Rupees
Brief: Supriya Lifescience Completion Of WHO Gmp Audit At Ambernath Facility
Brief: Supriya Lifescience Dec-Quarter Profit 467.8 Mln Rupees
India's Supriya Lifescience rises on opening new production block
Brief: Supriya Lifescience Inaugurates Module E Production Block at Lote Parshuram, Maharashtra
Brief: Supriya Lifescience Gets Approval From Brazil's Anvisa For Esketamine Hydrochloride
India's Supriya Lifescience gains on strong Q2 results
Brief: Supriya Lifescience Says Sept-Quarter Profit At 461.5 Million Rupees
India's Supriya Lifescience hits over 2-year high on Q1 profit rise
Brief: Supriya Lifescience Says Change In Designation Of Saloni Wagh As MD
India's Supriya Lifescience hits over 2-year high on Q3 profit climb
Brief: Supriya Lifescience Dec-Quarter Profit Rises
Brief: Supriya Lifescience Approved Capital Expenditure Plan At Ambernath Site For CDMO Facility